Pre-order Enquiry
Request Free Sample
Global Non-Small Cell Lung Cancer Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-14116249 | Publishing Date : 18-Apr-2019 | No. of pages : 97
Detailed TOC of Global Non-Small Cell Lung Cancer Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Table of ContentsNon-Small Cell Lung Cancer Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Non-Small Cell Lung Cancer Therapeutics
1.1 Non-Small Cell Lung Cancer Therapeutics Market Overview
1.1.1 Non-Small Cell Lung Cancer Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Non-Small Cell Lung Cancer Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Non-Small Cell Lung Cancer Therapeutics Market by Type
1.3.1 Biologics
1.3.2 Small molecules
1.4 Non-Small Cell Lung Cancer Therapeutics Market by End Users/Application
1.4.1 Hospital
1.4.2 Clinic
2 Global Non-Small Cell Lung Cancer Therapeutics Competition Analysis by Players
2.1 Non-Small Cell Lung Cancer Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GlaxoSmithKline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 AstraZeneca
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Bristol-Myers Squibb
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Pfizer
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Eli Lilly
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Sanofi
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Non-Small Cell Lung Cancer Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
4 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Non-Small Cell Lung Cancer Therapeutics in Future
4.4 Top Consumer/End Users of Non-Small Cell Lung Cancer Therapeutics
5 North America Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
5.1 North America Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
5.2 North America Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
6.1 Europe Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
6.2 Europe Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
7.1 China Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
7.2 China Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
9.1 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
9.2 Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Development Status and Outlook
10.1 Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Non-Small Cell Lung Cancer Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2025)
12 Non-Small Cell Lung Cancer Therapeutics Market Dynamics
12.1 Non-Small Cell Lung Cancer Therapeutics Market Opportunities
12.2 Non-Small Cell Lung Cancer Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Non-Small Cell Lung Cancer Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Non-Small Cell Lung Cancer Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Figures, Tables and Charts Available in Global Non-Small Cell Lung Cancer Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
List of Tables and FiguresFigure Non-Small Cell Lung Cancer Therapeutics Product Scope
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) (2014-2019)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Regions in 2018
Figure North America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Type in 2018
Figure Biologics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Small molecules Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Hospital
Figure Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2014-2019)
Table Key Downstream Customer in Clinic
Figure Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2014-2019)
Table Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Table GlaxoSmithKline Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2014-2019)
Figure GlaxoSmithKline Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Novartis Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Novartis (2014-2019)
Figure Novartis Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table AstraZeneca Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of AstraZeneca (2014-2019)
Figure AstraZeneca Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Roche Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Roche (2014-2019)
Figure Roche Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Bristol-Myers Squibb Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (2014-2019)
Figure Bristol-Myers Squibb Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Pfizer Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Pfizer (2014-2019)
Figure Pfizer Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Eli Lilly Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Eli Lilly (2014-2019)
Figure Eli Lilly Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Sanofi Basic Information List
Table Non-Small Cell Lung Cancer Therapeutics Business Revenue (Million USD) of Sanofi (2014-2019)
Figure Sanofi Non-Small Cell Lung Cancer Therapeutics Business Revenue Market Share in 2018
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2014
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2015
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2016
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2017
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2018
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2019
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Non-Small Cell Lung Cancer Therapeutics
Figure North America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure North America Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure Europe Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure China Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Market Size Share by Players in 2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Regions in 2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Regions in 2025
Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type in 2025
Table Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) by Application in 2025
Keyplayers in Global Non-Small Cell Lung Cancer Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
GlaxoSmithKlineNovartis
AstraZeneca
Roche
Bristol-Myers Squibb
Pfizer
Eli Lilly
Sanofi
Request Sample
Request Discount
